References
- Ballenger JC, Burrows GD, DuPont RL Jr.: Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 45:413-422, 1988
- Rickels K, Schweizer E, Case WG, Greenblatt DJ: Long-term therapeutic use of benzodiazipines: Effects of abrupt discontinuation. Arch Gen Psychiatry 47:899–907, 1990
- Schweizer E, Rickels K, Case WG, Greenblatt DJ: Long-term therapeutic use of benzodiazipines. II. Ef-fects of gradual taper. Arch Gen Psychiatry 47:899–907, 1990
- Beck AT, Brown G, Epstein N, Steer RA: An inventory for measuring clinical anxiety: Psychometric proper-ties. J Consult Clin Psychol 56:893–897, 1988
- Zung WWK: A rating instrument for anxiety disor-ders. Psychosomatics 12:371–379, 1971
- Hamilton M: The assessment of anxiety states by rat-ing. Br J Med Psychol 32:50–55, 1959
- Hamilton MA: Rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62, 1960
- Derogatis LR, Lipman RS, Covi L: SCL-90: An out-patient psychiatric rating scale—Preliminary report. Psychopharmacol Bull 9:13–28, 1973
- Cooper J: The Leyton Obsessional Inventory. Psychol Med 1:48–64, 1970
- Scavone JM, Greenblatt DJ, Shader RI: Alprazolam kinetics following sublingual and oral administration. J Clin Psychopharmacol 7:332–334, 1987